Literature DB >> 3770357

A case of familial hyper-cholinesterasemia associated with isozyme variant band.

K Yamamoto, F Morito, M Motomura, H Kaneoka, T Sakai.   

Abstract

Familial cases of serum hyper-cholinesterase (chE) activity are reported. The serum chE activity in seven consanguineous members so examined proved to be elevated up to twice the normal level. In these cases, all plausible diseases that might be the culprit for the hyper-chE activity were denied by the biochemical, hormonal, and morphological examinations; fatty liver was excluded by liver biopsy. So far, there have only been two descriptions of familial cases of high serum chE activity. The serum chE isozyme analysis revealed an extra band between bands 3 and 4 only in the subjects associated with serum hyper-chE activity. No definite extra band could be detected in the serum of normal subjects or even in the subjects diagnosed as fatty liver with high level of serum chE activity. The distribution characteristics of the members with the increased chE activity and the existence of an extra band suggest that the inheritance is autosomal dominant. This is the first report to demonstrate an extra band between bands 3 and 4 in cases of familial hyper-chE. The detection of this extra band on serum chE isozyme analysis may be helpful for the diagnosis of genetically determined hyper-chE.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3770357     DOI: 10.1007/bf02774136

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  15 in total

1.  Serum-cholinesterase levels in diabetes mellitus.

Authors:  R H THOMPSON; J R TROUNCE
Journal:  Lancet       Date:  1956-05-12       Impact factor: 79.321

2.  A relationship between body fat and plasma pseudo-cholinesterase.

Authors:  W T BERRY; P J COWIN; D R DAVIES
Journal:  Br J Nutr       Date:  1954       Impact factor: 3.718

3.  Cholinesterase in serum and low density lipoprotein of hyperlipidemic patients.

Authors:  M I Chu; P Fontaine; K M Kutty; D Murphy; R Redheendran
Journal:  Clin Chim Acta       Date:  1978-04-03       Impact factor: 3.786

4.  Increased serum gamma-glutamyltransferase in hypertriglyceridemia: comparison with serum pseudocholinesterase.

Authors:  M Cucuianu; D Zdrenghea; M Pop; A Opincaru
Journal:  Clin Chim Acta       Date:  1976-09-20       Impact factor: 3.786

5.  Studies on plasma cholinesterase isoenzymes in glaucoma.

Authors:  P Juul; I H Leopold
Journal:  Am J Ophthalmol       Date:  1968-04       Impact factor: 5.258

6.  A pseudocholinesterase variant (E Cynthiana) associated with elevated plasma enzyme activity.

Authors:  A Yoshida; A G Motulsky
Journal:  Am J Hum Genet       Date:  1969-09       Impact factor: 11.025

7.  [Serum cholinesterase activity in non-alcoholic fatty liver. Effect of obesity on the activity and role of its measurement in the differential diagnosis in chronic hepatitis].

Authors:  F Nomura; K Ohnishi; H Koen; T Ohtsuki; K Kohno; M Saitoh; T Nakayama; H Hatano; A Mishima; Y Hiyama
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1984-07

8.  Separation of serum cholinesterase isozymes by an improved polyacrylamide gel electrophoresis and its application for the study of liver diseases (Part I).

Authors:  S Matsuzaki; K Iwamura; T Katsunuma; H Kamiguchi
Journal:  Gastroenterol Jpn       Date:  1980

9.  Abnormalities of serum cholinesterase isozyme in liver cirrhosis and hepatoma (Part II).

Authors:  S Matsuzaki; K Iwamura; M Itakura; T Katsunuma
Journal:  Gastroenterol Jpn       Date:  1980

10.  Similar behaviour of lecithin:cholesterol acyltransferase and pseudocholinesterase in liver disease and hyperlipoproteinemia.

Authors:  M Cucuianu; A Opincaru; D Tapalagă
Journal:  Clin Chim Acta       Date:  1978-04-03       Impact factor: 3.786

View more
  1 in total

1.  Characterization of serum cholinesterase in familial hyper-cholinesterasemia associated with an isozyme variant band.

Authors:  K Yamamoto; F Morito; Y Setoguchi; S Fujii; T Kariya; T Sakai
Journal:  Gastroenterol Jpn       Date:  1987-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.